keyword
https://read.qxmd.com/read/38646606/characteristics-of-users-and-new-initiators-of-single-and-multiple-inhaler-triple-therapy-for-chronic-obstructive-pulmonary-disease-in-germany
#1
JOURNAL ARTICLE
Kai-Michael Beeh, Kieran J Rothnie, Jing Claussen, Fränce Hardtstock, Rachel K Knapp, Thomas Wilke, Alexandrosz Czira, Chris Compton, Afisi S Ismaila
PURPOSE: To assess patient characteristics of users and new initiators of triple therapy for chronic obstructive pulmonary disease (COPD) in Germany. PATIENTS AND METHODS: Retrospective cohort study of patients with COPD and ≥1 prescription for single-inhaler triple therapy (SITT; fluticasone furoate/umeclidinium/vilanterol [FF/UMEC/VI] or beclomethasone dipropionate/glycopyrronium bromide/formoterol [BDP/GLY/FOR]) or multiple-inhaler triple therapy (MITT), using data from the AOK PLUS German sickness fund (1 January 2015-31 December 2019)...
2024: International Journal of Chronic Obstructive Pulmonary Disease
https://read.qxmd.com/read/38646225/the-safety-and-effectiveness-of-bevacizumab-in-metastatic-colorectal-cancer-with-unresectable-metastases-a-real-life-study-from-the-south-of-morocco
#2
JOURNAL ARTICLE
Ghizlane Rais, Farah Boutaagount, Rania Mokfi, Meryem Maskrout, Soundous Bennour, Chaymae Senoussi, Fadoua Rais, Laila Lahlou
Background Colorectal cancer constitutes a significant public health challenge, despite remarkable strides made in the last two decades, particularly in the medical management of metastatic stages. Notable progress has been achieved through targeted therapies such as anti-epidermal growth factor receptors or anti-angiogenic antibodies, as well as advancements in surgical approaches for hepatic metastases. This study seeks to assess the efficacy and safety of bevacizumab plus chemotherapy in individuals with metastatic colorectal cancer...
March 2024: Curēus
https://read.qxmd.com/read/38646184/relationship-of-nocturnal-insomnia-symptoms-and-outcomes-after-hypoglossal-nerve-stimulation
#3
JOURNAL ARTICLE
Reena Dhanda Patil, Maria V Suurna, Armin Steffen, Ryan Soose, James Coxe, Teresa Chan, Stacey L Ishman
OBJECTIVE: In patients undergoing hypoglossal nerve stimulation (HGNS), we examined the Insomnia Severity Index (ISI) to understand how baseline sleep onset insomnia (SOI), sleep maintenance insomnia (SMI), and early morning awakening (EMA) affected postsurgical outcomes. STUDY DESIGN: Observational. SETTING: Multicenter registry. METHODS: We included patients from the Adherence and Outcomes of Upper Airway Stimulation for Obstructive Sleep Apnea International Registry (ADHERE) with a baseline ISI from 2020 to 2023...
2024: OTO Open
https://read.qxmd.com/read/38645990/effect-of-s-ketamine-on-postoperative-nausea-and-vomiting-in-patients-undergoing-video-assisted-thoracic-surgery-a-randomized-controlled-trial
#4
Yu Qi, Meiyan Zhou, Wenting Zheng, Yaqi Dong, Weihua Li, Long Wang, Haijun Xu, Miao Zhang, Dunpeng Yang, Liwei Wang, Hai Zhou
PURPOSE: Postoperative nausea and vomiting (PONV) frequently occur in patients after surgery. In this study, the authors investigated whether perioperative S-ketamine infusion could decrease the incidence of PONV in patients undergoing video-assisted thoracoscopic surgery (VATS) lobectomy. PATIENTS AND METHODS: This prospective, randomized, double-blinded, controlled study was conducted a total of 420 patients from September 2021 to May 2023 at Xuzhou Central Hospital in China, who underwent elective VATS lobectomy under general anesthesia with tracheal intubation...
2024: Drug Design, Development and Therapy
https://read.qxmd.com/read/38645987/clinical-application-and-research-progress-of-remimazolam-for-pediatric-patients
#5
REVIEW
Chen Bai, Mingcan Xu, Yan Guo, Yanwu Jin, Xin Zhao
Remimazolam is a novel ultrashort-acting benzodiazepine that allosterically modulates γ-aminobutyric acid type A (GABAA) receptors to exert sedative effects. Remimazolam has the properties of controllable sedation, rapid onset, and a short duration of action, along with minor depression of circulation and respiration. Remimazolam has been approved for clinical use since 2020 in Japan, and it has been applied for procedural sedation, general anesthesia induction and maintenance, and sedation in ICU patients, and has been proven to be safe and effective...
2024: Drug Design, Development and Therapy
https://read.qxmd.com/read/38645919/rituximab-mycophenolate-combination-therapy-in-children-with-calcineurin-inhibitor-resistant-fsgs
#6
JOURNAL ARTICLE
Saumil Gaur, Partha P Paul, Mounika Motamarri
INTRODUCTION: There is a paucity of data and therapeutic options nationally and internationally on calcineurin inhibitor (CNI)-resistant forms of focal segmental glomerulosclerosis (FSGS) in children. CNI (tacrolimus or cyclosporine) are proven monotherapy in children with FSGS with a steroid-dependent (SD) or steroid-resistant (SR) course. We analyzed a novel therapeutic option in CNI-resistant FSGS by using the dual therapy of rituximab and mycophenolate to maintain remission. METHODS: This is a retrospective analysis of clinical, therapeutic profile, and treatment outcomes (sustained remission versus no remission) in subjects with CNI-resistant FSGS who received dual rituximab therapy along with mycophenolate as maintenance therapy for a minimum of 1 year...
2024: Indian Journal of Nephrology
https://read.qxmd.com/read/38645911/anca-associated-vasculitis-practical-issues-in-management
#7
REVIEW
Tayeba Roper, Alan David Salama
ANCA associated vasculitides are multi-system autoimmune diseases which are increasing in prevalence. In this review we will discuss the clinical manifestations and review the management options. We highlight the various trials of induction and maintenance therapy and discuss the areas of unmet need. These include understanding which patients are at highest risk of relapse, clinical adaptation of improved biomarkers of disease activity and tools to discuss long term prognosis.
2024: Indian Journal of Nephrology
https://read.qxmd.com/read/38645180/identification-of-determinants-that-allow-maintenance-of-high-level-fluoroquinolone-resistance-in-acinetobacter-baumannii
#8
Efrat Hamami, Wenwen Huo, Juan Hernandez-Bird, Arnold Castaneda, Jinna Bai, Sapna Syal, Juan C Ortiz-Marquez, Tim van Opijnen, Edward Geisinger, Ralph R Isberg
UNLABELLED: Acinetobacter baumannii is associated with multidrug resistant (MDR) infections in healthcare settings, with fluoroquinolones such as ciprofloxacin being currently ineffective. Clinical isolates largely harbor mutations in the GyrA and TopoIV fluoroquinolone targets, as well as mutations that increase expression of drug resistance-nodulation-division (RND) efflux pumps. Factors critical for maintaining fitness levels of pump overproducers are uncharacterized despite their prevalence in clinical isolates...
April 8, 2024: bioRxiv
https://read.qxmd.com/read/38645153/role-of-numa1-in%C3%A2-breast-cancer-stem-cells-with-implications-for-combination-therapy-of-pim1-and-autophagy-inhibition-in-triple-negative-breast-cancer
#9
Kanakaraju Manupati, Mingang Hao, Michael Haas, Syn Kok Yeo, Jun-Lin Guan
BACKGROUND: Nuclear mitotic apparatus protein 1 (NuMA1) is a cell cycle protein and upregulated in breast cancer. However, the role of NuMA1 in TNBC and its regulation in heterogenous populations remains elusive. METHODS: We performed CRISPR mediated deletion of NuMA1 in mouse TNBC cells, BF3M. FACS was utilized to isolate BCSCs, and bulk cells based on CD29 and CD61 markers. Cell viability, migration, and invasion ability of BCSCs and bulk cells was evaluated using MTT, wound healing and transwell invasion assays, respectively...
April 1, 2024: Research Square
https://read.qxmd.com/read/38645003/pilot-trial-of-perampanel-on-peritumoral-hyperexcitability-and-clinical-outcomes-in-newly-diagnosed-high-grade-glioma
#10
Steven Tobochnik, Michael S Regan, Maria K C Dorotan, Dustine Reich, Emily Lapinskas, Md Amin Hossain, Sylwia A Stopka, Sandro Santagata, Melissa M Murphy, Omar Arnaout, Wenya L Bi, E Antonio Chiocca, Alexandra J Golby, Michael A Mooney, Timothy R Smith, Keith L Ligon, Patrick Y Wen, Nathalie Y R Agar, Jong Woo Lee
Background Glutamatergic neuron-glioma synaptogenesis and peritumoral hyperexcitability promote glioma growth in a positive feedback loop. The objective of this study was to evaluate the feasibility and estimated effect sizes of the AMPA-R antagonist, perampanel, on intraoperative electrophysiologic hyperexcitability and clinical outcomes. Methods An open-label trial was performed comparing perampanel to standard of care (SOC) in patients undergoing resection of newly-diagnosed radiologic high-grade glioma...
April 18, 2024: medRxiv
https://read.qxmd.com/read/38644935/impact-of-everolimus-initiation-and-corticosteroid-weaning-during-acute-phase-after-heart-transplantation-on-clinical-outcome-data-from-the-korean-organ-transplant-registry-kotry
#11
JOURNAL ARTICLE
Kyu-Sun Lee, Hyungseop Kim, Sun Hwa Lee, Dong-Ju Choi, Minjae Yoon, Eun-Seok Jeon, Jin-Oh Choi, Jeehoon Kang, Hae-Young Lee, Sung-Ho Jung, Jaewon Oh, Seok-Min Kang, Soo Yong Lee, Min Ho Ju, Jae-Joong Kim, Myoung Soo Kim, Hyun-Jai Cho
The effect of changes in immunosuppressive therapy during the acute phase post-heart transplantation (HTx) on clinical outcomes remains unclear. This study aimed to investigate the effects of changes in immunosuppressive therapy by corticosteroid (CS) weaning and everolimus (EVR) initiation during the first year post-HTx on clinical outcomes. We analyzed 622 recipients registered in the Korean Organ Transplant Registry (KOTRY) between January 2014 and December 2021. The median age at HTx was 56 years (interquartile range [IQR], 45-62), and the median follow-up time was 3...
2024: Transplant International
https://read.qxmd.com/read/38644518/real-world-use-of-long-acting-cabotegravir-and-rilpivirine-12-month-results-of-the-injectable-antiretroviral-therapy-feasibility-study-jabs
#12
JOURNAL ARTICLE
M John, L Williams, G Nolan, M Bonnett, A Castley, D Nolan
OBJECTIVES: The inJectable Antiretroviral feasiBility Study (JABS) aimed to evaluate the implementation of long-acting regimens in a 'real world' Australian setting, with inclusion of participants with complex medical needs, social vulnerability and/or historical non-adherence. METHODS: JABS was a 12-month, single-centre, single-arm, open-label phase IV study of long-acting cabotegravir 600 mg plus rilpivirine 900 mg administered intramuscularly every 2 months to adults with treated HIV-1 infection...
April 21, 2024: HIV Medicine
https://read.qxmd.com/read/38644236/-chinese-expert-consensus-on-maintenance-treatment-with-anti-egfr-monoclonal-antibody-for-ras-wild-type-metastatic-colorectal-cancer-2024-edition
#13
JOURNAL ARTICLE
(no author information available yet)
For patients with metastatic colorectal cancer (mCRC) who achieve disease control during first-line standard therapy, post-induction strategies should emphasize on quality of life improvement while maintaining disease control. Chemotherapy combined with anti-epidermal growth factor receptor (EGFR) monoclonal antibody is the standard first-line treatment for RAS wild-type mCRC patients. After anti-EGFR-based first-line induction therapy achieves at least stable disease, anti-EGFR-based maintenance treatment could maintain disease control while keeping a good safety profile...
April 25, 2024: Zhonghua Wei Chang Wai Ke za Zhi, Chinese Journal of Gastrointestinal Surgery
https://read.qxmd.com/read/38644208/-cutting-edge-of-diagnosis-and-treatment-for-chronic-inflammatory-demyelinating-polyradiculoneuropathy-cidp-based-on-the-ean-pns-guideline-2021
#14
JOURNAL ARTICLE
Satoshi Kuwabara
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a most common chronic immune-mediated demyelinating neuropathy, and includes a number of clinical subtypes. The major phenotype is "typical CIDP", which is characterized by symmetric polyneuropathy and "proximal and distal" muscle weakness. During the historical changes in the concept of CIDP, multifocal motor neuropathy, anti-myelin-associated glycoprotein (MAG) neuropathy, and autoimmune nodopathy have been excluded. Currently CIDP is considered as a syndrome including typical CIDP and CIDP variant such as distal CIDP and multifocal CIDP...
April 20, 2024: Rinshō Shinkeigaku, Clinical Neurology
https://read.qxmd.com/read/38643837/e2f1-regulated-usp5-contributes-to-the-tumorigenic-capacity-of-glioma-stem-cells-through-the-maintenance-of-oct4-stability
#15
JOURNAL ARTICLE
Xiao Jiang, Hongtao You, Yixuan Niu, Yudan Ding, Zhengxin Chen, Huibo Wang, Yuan Xu, Peng Zhou, Li Wei, Danni Deng, Lian Xue, Ya Peng, Yilin Yang, Ligang Fan, Naiyuan Shao
Mesenchymal glioma stem cells (MES GSCs) are a subpopulation of cells in glioblastoma (GBM) that contribute to a worse prognosis owing to their highly aggressive nature and resistance to radiation therapy. Here, OCT4 is characterized as a criticial factor in sustaining the stemness phenotype of MES GSC. We find that OCT4 is expressed intensively in MES GSC and is intimately associated with poor prognosis, moreover, OCT4 depletion leads to diminished invasive capacity and impairment of the stem phenotype in MES GSC...
April 19, 2024: Cancer Letters
https://read.qxmd.com/read/38642437/antidepressants-compared-to-placebo-for-people-with-binge-eating-disorder-a-systematic-review-and-meta-analysis
#16
REVIEW
Angeliki L Sioziou, Andreas S Lappas, Menelaos Skarlatos, Christina Mesiari, Maria C Florou, Aikaterini Argyrou, Nikos Christodoulou, Michail Chourdakis, Myrto Samara
Binge eating disorder (BED) is the most prevalent eating disorder. Treatment options include pharmacotherapy as well as psychotherapy, with the latter recommended as a first-line option. However, the use of psychotherapeutic interventions poses several challenges. Antidepressants are easily accessible, but they lack robust evidence-base. This systematic review aims to comprehensively examine the efficacy and safety of antidepressants for the treatment of BED. Five databases were searched for randomized controlled trials (RCTs) comparing antidepressants vs...
April 19, 2024: European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology
https://read.qxmd.com/read/38642090/probiotics-supplements-improve-the-sarcopenia-related-quality-of-life-in-older-adults-with-age-related-muscle-decline
#17
JOURNAL ARTICLE
Rizwan Qaisar, Ayousha Burki, Asima Karim, M Shahid Iqbal, Firdos Ahmad
A pathological increase in intestinal leak is implicated in age-associated muscle loss, termed sarcopenia, and reduced sarcopenia-related quality-of-life (SarQoL). However, the potential therapies remain elusive. We investigated the effects of probiotic supplementation on sarcopenia and SarQoL in geriatric older adults. We randomized sarcopenic men into placebo (age = 71.4 ± 3.9 years, n = 63) and probiotic (age = 73 ± 4.1 years, n = 60) groups for 16 weeks...
April 20, 2024: Calcified Tissue International
https://read.qxmd.com/read/38641147/borderline-rejection-to-treat-or-not-to-treat
#18
JOURNAL ARTICLE
Alessandra Palmisano, Marta D'Angelo, Ilaria Gandolfini, Marco Delsante, Giovanni Maria Rossi, Micaela Gentile, Enrico Fiaccadori, Paolo Cravedi, Umberto Maggiore
INTRODUCTION: It is unclear whether kidney transplant recipients with a biopsy diagnosis as a "borderline" acute T-cell mediated rejection (TCMR) requires the treatment with intravenous (iv) steroids pulse plus/minus intensification of the maintenance therapy (TRT) in comparison with the simple clinical follow-up (F-UP). METHODS: We retrospectively followed a consecutive series of kidney transplant recipients diagnosed with a borderline acute TCMR at biopsy by surveillance or clinical indication for 12 months and compared TRT and F-UP groups...
April 17, 2024: Transplant Immunology
https://read.qxmd.com/read/38641025/butyrate-as-a-potential-therapeutic-agent-for-neurodegenerative-disorders
#19
JOURNAL ARTICLE
Prapti Chakraborty, Hasinika K A H Gamage, Angela S Laird
Maintaining an optimum microbial community within the gastrointestinal tract is intricately linked to human metabolic, immune and brain health. Disturbance to these microbial populations perturbs the production of vital bioactive compounds synthesised by the gut microbiome, such as short-chain fatty acids (SCFAs). Of the SCFAs, butyrate is known to be a major source of energy for colonocytes and has valuable effects on the maintenance of intestinal epithelium and blood brain barrier integrity, gut motility and transit, anti-inflammatory effects, and autophagy induction...
April 17, 2024: Neurochemistry International
https://read.qxmd.com/read/38640773/secondary-cytoreductive-surgery-and-oncologic-outcomes-in-the-era-of-targeted-maintenance-therapy-for-recurrent-platinum-sensitive-ovarian-cancer
#20
JOURNAL ARTICLE
Sarah Ehmann, Clarissa Lam, Qin Zhou, Alexia Iasonos, Rachel N Grisham, William P Tew, Roisin E O'Cearbhaill, Kara Long Roche, Oliver Zivanovic, Yukio Sonoda, Dennis S Chi, Ginger J Gardner
OBJECTIVES: To compare oncologic outcomes of secondary cytoreductive surgery (SCS) before and after FDA approval of Poly(ADP-ribose) polymerase inhibitor (PARPi) and bevacizumab maintenance therapies for platinum-sensitive recurrent ovarian cancer (PS-ROC). METHODS: Patients who underwent SCS for first recurrence of PS-ROC from 1/1/2013-1/1/2020 were identified. Exclusion criteria included prior chemotherapy for recurrence, bowel obstruction procedures, and palliative surgery...
April 18, 2024: Gynecologic Oncology
keyword
keyword
57204
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.